Long ago, during the European Renaissance, Leonardo da Vinci wrote that we humans “know more about the movement of celestial bodies than about the soil underfoot.” Five hundred years and innumerable technological and scientific advances later, his sentiment still holds true. But that could soon change. A new study in Nature Communications details how an improved method for studying microbes in the soil will help scientists understand both fine-grained details and large-scale cycles of the environment.
A new biosynthetic production pathway developed by scientists at the Joint BioEnergy Institute could provide a sustainable alternative to conventional synthetic blue dye. The highly efficient fungi-based platform may also open the door for producing many other valuable biological compounds that are currently very hard to manufacture.
Marking a step forward in Berkeley Lab’s vision to expand the footprint of the biological and environmental sciences, the Integrative Genomics Building (IGB) was dedicated during a two-hour ceremony that culminated in the cutting of a double helix ribbon representing DNA. By uniting leading experts and world-class technologies under one roof, the IGB will help transform plant and microbial genomics research into solutions for today’s most pressing environmental and energy issues.
A study led by Berkeley Lab has uncovered new insight into how to better control the catalyst cobalt oxide for artificial photosynthesis.
For years, routine testing has shown that watersheds of the Mahaulepu Valley and Waikomo Stream in southeast Kauai frequently contain high counts of potentially pathogenic fecal indicator bacteria (FIB). To better understand the cause of the high FIB counts, the DOH commissioned a study by Berkeley Lab microbial ecologists Gary Andersen and Eric Dubinsky. After using a powerful microbial detection tool called the PhyloChip, the scientists concluded that most of the past monitoring results were false positives.
An open-source RNA analysis platform has been successfully used on plant cells for the first time – a breakthrough that could herald a new era of fundamental research and bolster efforts to engineer more efficient food and biofuel crop plants. The technology, called Drop-seq, is a method for measuring the RNA present in individual cells, allowing scientists to see what genes are being expressed and how this relates to the specific functions of different cell types.
Four Lawrence Berkeley National Laboratory (Berkeley Lab) scientists have been elected into the National Academy of Sciences (NAS) in recognition of their exemplary past and and continuing original research.
Scientists have invented a new “synthetic antibody” that could make screening for diseases easier and less expensive than current go-to methods. Writing in the journal Nano Letters, a team led by Markita Landry of Berkeley Lab and UC Berkeley describes how peptoids – synthetically produced molecules, first created by Ron Zuckermann at Berkeley Lab’s Molecular Foundry, that
Mice have been instrumental in the study of cancer, but like all animal models of human diseases, they have their limitations. For stomach cancer in particular, mice have historically been regarded as quite poor research organisms because rodents rarely develop spontaneous stomach tumors. But results from a new study are about to shake up the paradigm.
Mina Bissell, a distinguished scientist at the Berkeley Lab, has been selected to receive two prestigious awards for her pioneering contributions to breast cancer biology and medicine.